SCHEMBL22128352

SCHEMBL22128352

COC(CO[Si](C)(C)C(C)(C)C)Cn1c(C)nc2ccc(Br)cc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.40
GALR3 O60755 1/20 0.34
NR2F2 P24468 1/20 0.34
LMNA P02545 5/20 0.33
MAPT P10636 5/20 0.33
TSHR P16473 3/20 0.33
HSD17B10 Q99714 1/20 0.33
FABP4 P15090 1/20 0.33
SMN1; SMN2 Q16637 5/20 0.33
HTT P42858 4/20 0.33
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
MAPK1 P28482 1/20 0.31
AGER Q15109 1/20 0.31
APAF1 O14727 1/20 0.31
BRD4 O60885 2/20 0.31
ALDH1A1 P00352 2/20 0.31
CRHBP P24387 1/20 0.31
CRHR2 Q13324 1/20 0.31
NPM1 P06748 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22128301 0.86 POLB (0.53) POLBGALR3NR2F2LMNAMAPT
SCHEMBL22122244 0.80 POLB (0.45) POLBGALR3NR2F2LMNAMAPT
SCHEMBL26979747 0.79 BRD4 (0.40) POLBGALR3NR2F2LMNAMAPT
SCHEMBL22152199 0.77 LMNA (0.43) POLBGALR3NR2F2LMNAMAPT
SCHEMBL25149332 0.72 CDK9 (0.47) POLBGALR3NR2F2LMNAMAPT
SCHEMBL31113507 0.72 CDK9 (0.47) POLBGALR3NR2F2LMNAMAPT
SCHEMBL15206112 0.70 GLP1R (0.42) LMNAMAPTHSD17B10FABP4MEN1
SCHEMBL22122428 0.69 LMNA (0.49) POLBGALR3NR2F2LMNAMAPT
SCHEMBL22122401 0.69 POLB (0.53) POLBGALR3NR2F2LMNAMAPT
SCHEMBL22122426 0.69 LMNA (0.49) POLBGALR3NR2F2LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240139185-A1 COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT 2024-05-02 US disclosed
CN-113498342-A Compounds involved in synergistic binding and uses thereof 锐新医药公司 2021-10-12 CN disclosed
WO-2020132597-A1 COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF Revolution Medicines, Inc. (US) 2020-06-25 WO disclosed
US-20200197391-A1 COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF Revolution Medicines, Inc. 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240139185-A1 COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF KRAS, NRAS, HRAS POLB 2323/4885GALR3 4115/4885NR2F2 2442/4885
US-20200197391-A1 COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF KRAS, NRAS, HRAS POLB 2323/4885GALR3 4115/4885NR2F2 2442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.